2nd Quarter - Report

INDIVIOR INC for INDIVIOR INC

Period 2nd Quarter 2024 Filed Jul 22, 2024 Signed by Frank Purcell

Official filing
Firm
INDIVIOR INC
Client
INDIVIOR INC
Income
—
Expenses
$260,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

SUPPORT for Patients and Communities Reauthorization Act (HR 4531 / S 2433, S 3106, S 3393); HEAL Act (HR 4007 / S 2809); PAHPA Act (HR 4421 / S 2333); Reentry Act (HR 2400 / S 1165); Due Process Continuity of Care Act (HR 3074 / S 971); FY24 Further Consolidated Appropriations Act (HR 2882), FY25 appropriations for Labor-HHS-Education, Military Construction & Veterans Affairs, and Commerce-Justice-Science; DEA rulemaking on telemedicine prescribing of controlled substances (RIN #1117-AB40)

LobbyistCovered position, as disclosed
FRANK J. PURCELL —

Contacted: HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); SENATE; Substance Abuse & Mental Health Services Administration (SAMHSA); Office of Natl Drug Control Policy (NDCP)

Bills named: H.R. 4007 (118th), H.R. 4421 (118th), H.R. 2400 (118th), H.R. 3074 (118th), H.R. 4531 (118th), H.R. 2882 (118th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.